Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T W Kim

Showing results (171-180 of 240) with videos related to

Pageof 24
Sort By:
Allergy|June 3, 2016
Enhanced Th2 cell differentiation and function in the absence of Nox2B-I Kwon, T W Kim, K Shin, et al.
British Journal of Cancer|February 21, 2012
Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinumD H Yoon, M-H Ryu, Y S Park, et al.
Clinical Transplantation|February 17, 2007
Spatulated end-to-end bile duct reconstruction in orthotopic liver transplantationAndrzej K Buczkowski, David F Schaeffer, Peter T W Kim, et al.
AIDS Care|May 18, 2023
Cannabis use frequency and pain interference among people with HIVT D Klepp, T C Heeren, M R Winter, et al.
British Journal of Cancer|April 21, 2012
Phase II and UGT1A1 genotype study of irinotecan dose escalation as salvage therapy for advanced gastric cancerJ-C Jo, J-L Lee, M-H Ryu, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|April 23, 2014
Combined pancreaticoduodenectomy and colon resection for locally advanced peri-ampullary tumours: analysis of peri-operative morbidity and mortalitySara J Temple, Peter T W Kim, Pablo E Serrano, et al.
British Journal of Cancer|January 19, 2005
Phase II study of capecitabine and cisplatin as first-line combination therapy in patients with gastric cancer recurrent after fluoropyrimidine-based adjuvant chemotherapyH J Kang, H M Chang, T W Kim, et al.
Clinical and Experimental Immunology|March 11, 2015
The siRNA cocktail targeting interleukin 10 receptor and transforming growth factor-β receptor on dendritic cells potentiates tumour antigen-specific CD8(+) T cell immunityY-H Ahn, S-O Hong, J H Kim, et al.
Pathology, Research and Practice|May 19, 2001
A prospective correlation of Laurén's histological classification of stomach cancer with clinicopathological findings including DNA flow cytometryK H Lee, J H Lee, J K Cho, et al.
Clinical and Experimental Immunology|May 20, 2011
Blocking the immunosuppressive axis with small interfering RNA targeting interleukin (IL)-10 receptor enhances dendritic cell-based vaccine potencyJ H Kim, T H Kang, K H Noh, et al.
Pageof 24

Showing results (171-180 of 240) with videos related to

Sort By:
Pageof 24
Allergy|June 3, 2016
Enhanced Th2 cell differentiation and function in the absence of Nox2B-I Kwon, T W Kim, K Shin, et al.
British Journal of Cancer|February 21, 2012
Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinumD H Yoon, M-H Ryu, Y S Park, et al.
Clinical Transplantation|February 17, 2007
Spatulated end-to-end bile duct reconstruction in orthotopic liver transplantationAndrzej K Buczkowski, David F Schaeffer, Peter T W Kim, et al.
AIDS Care|May 18, 2023
Cannabis use frequency and pain interference among people with HIVT D Klepp, T C Heeren, M R Winter, et al.
British Journal of Cancer|April 21, 2012
Phase II and UGT1A1 genotype study of irinotecan dose escalation as salvage therapy for advanced gastric cancerJ-C Jo, J-L Lee, M-H Ryu, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|April 23, 2014
Combined pancreaticoduodenectomy and colon resection for locally advanced peri-ampullary tumours: analysis of peri-operative morbidity and mortalitySara J Temple, Peter T W Kim, Pablo E Serrano, et al.
British Journal of Cancer|January 19, 2005
Phase II study of capecitabine and cisplatin as first-line combination therapy in patients with gastric cancer recurrent after fluoropyrimidine-based adjuvant chemotherapyH J Kang, H M Chang, T W Kim, et al.
Clinical and Experimental Immunology|March 11, 2015
The siRNA cocktail targeting interleukin 10 receptor and transforming growth factor-β receptor on dendritic cells potentiates tumour antigen-specific CD8(+) T cell immunityY-H Ahn, S-O Hong, J H Kim, et al.
Pathology, Research and Practice|May 19, 2001
A prospective correlation of Laurén's histological classification of stomach cancer with clinicopathological findings including DNA flow cytometryK H Lee, J H Lee, J K Cho, et al.
Clinical and Experimental Immunology|May 20, 2011
Blocking the immunosuppressive axis with small interfering RNA targeting interleukin (IL)-10 receptor enhances dendritic cell-based vaccine potencyJ H Kim, T H Kang, K H Noh, et al.
Pageof 24